What Causes Hypertrophic Cardiomyopathy?

被引:28
作者
Maron, Bradley A. [1 ]
Wang, Rui-Sheng [2 ]
Carnethon, Mercedes R. [3 ]
Rowin, Ethan J. [4 ]
Loscalzo, Joseph [1 ]
Maron, Barry J. [4 ]
Maron, Martin S. [4 ]
机构
[1] Harvard Med Sch, Dept Med, Div Cardiovasc Med, Boston 02115, MA USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA
[3] Feinberg Sch Med, Div Pulmonol & Crit Care, Chicago, IL USA
[4] Lahey Hosp & Med Ctr, HCM Ctr, Burlington, MA USA
关键词
CARDIAC-HYPERTROPHY; METABOLIC ABNORMALITIES; MYOCARDIAL FIBROSIS; MAGNETIC-RESONANCE; SYSTEMIC-SCLEROSIS; CLINICAL-COURSE; DISEASE; ASSOCIATION; SPECTROSCOPY; TACROLIMUS;
D O I
10.1016/j.amjcard.2022.06.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertrophic cardiomyopathy (HCM) is a global and relatively common cause of patient morbidity and mortality and is among the first reported monogenic cardiac diseases. For 30 years, the basic etiology of HCM has been attributed largely to variants in individual genes encoding cardiac sarcomere proteins, with the implication that HCM is fundamen-tally a genetic disease. However, data from clinical and network medicine analyses, as well as contemporary genetic studies show that single gene variants do not fully explain the broad and diverse HCM clinical spectrum. These transformative advances place a new focus on possible novel interactions between acquired disease determinants and genetic context to produce complex HCM phenotypes, also offering a measure of caution against overemphasizing monogenics as the principal cause of this disease. These new perspectives in which HCM is not a uniformly genetic disease but likely explained by multifactorial eti-ology will also unavoidably impact how HCM is viewed by patients and families in the clin-ical practicing community going forward, including relevance to genetic counseling and access to healthcare insurance and psychosocial wellness. Published by Elsevier Inc.
引用
收藏
页码:74 / 82
页数:9
相关论文
共 86 条
  • [61] The Hypertrophic Cardiomyopathy Phenotype Viewed Through the Prism of Multimodality Imaging Clinical and Etiologic Implications
    Rowin, Ethan J.
    Maron, Barry J.
    Maron, Martin S.
    [J]. JACC-CARDIOVASCULAR IMAGING, 2020, 13 (09) : 2002 - 2016
  • [62] P-31 MR SPECTROSCOPY IN HYPERTROPHIC CARDIOMYOPATHY - COMPARISON WITH TL-201 MYOCARDIAL PERFUSION IMAGING
    SAKUMA, H
    TAKEDA, K
    TAGAMI, T
    NAKAGAWA, T
    OKAMOTO, S
    KONISHI, T
    NAKANO, T
    [J]. AMERICAN HEART JOURNAL, 1993, 125 (05) : 1323 - 1328
  • [63] Signaling to Cardiac Hypertrophy: Insights from Human and Mouse RASopathies
    Sala, Valentina
    Gallo, Simona
    Leo, Christian
    Gatti, Stefano
    Gelb, Bruce D.
    Crepaldi, Tiziana
    [J]. MOLECULAR MEDICINE, 2012, 18 (06) : 938 - 947
  • [64] NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension
    Samokhin, Andriy O.
    Stephens, Thomas
    Wertheim, Bradley M.
    Wang, Rui-Sheng
    Vargas, Sara O.
    Yung, Lai-Ming
    Cao, Minwei
    Brown, Marcel
    Arons, Elena
    Dieffenbach, Paul B.
    Fewell, Jason G.
    Matar, Majed
    Bowman, Frederick P.
    Haley, Kathleen J.
    Alba, George A.
    Marino, Stefano M.
    Kumar, Rahul
    Rosas, Ivan O.
    Waxman, Aaron B.
    Oldham, William M.
    Khanna, Dinesh
    Graham, Brian B.
    Seo, Sachiko
    Gladyshev, Vadim N.
    Yu, Paul B.
    Fredenburgh, Laura E.
    Loscalzo, Joseph
    Leopold, Jane A.
    Maron, Bradley A.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (445)
  • [65] Satish O Sai, 2002, Indian Heart J, V54, P208
  • [66] Tacrolimus: A cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients?
    Scott, JS
    Boyle, GJ
    Daubeney, PE
    Miller, SA
    Law, Y
    Pigula, F
    Griffith, BP
    Webber, SA
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 82 - 83
  • [67] Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy
    Senthil, V
    Chen, SN
    Tsybouleva, N
    Halder, T
    Nagueh, SF
    Willerson, JT
    Roberts, R
    Marian, AJ
    [J]. CIRCULATION RESEARCH, 2005, 97 (03) : 285 - 292
  • [68] Cardiomyocyte-Specific Telomere Shortening is a Distinct Signature of Heart Failure in Humans
    Sharifi-Sanjani, Maryam
    Oyster, Nicholas M.
    Tichy, Elisia D.
    Bedi, Kenneth C., Jr.
    Harel, Ofer
    Margulies, Kenneth B.
    Mourkioti, Foteini
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (09):
  • [69] Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death
    Shirani, J
    Pick, R
    Roberts, WC
    Maron, BJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (01) : 36 - 44
  • [70] Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy
    Sridharan, Aadhavi
    Maron, Martin S.
    Carrick, Richard T.
    Madias, Christopher A.
    Huang, Dou
    Cooper, Craig
    Drummond, Jennifer
    Maron, Barry J.
    Rowin, Ethan J.
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2022, 33 (01) : 20 - 29